GlassScriptPhysician profile
Thomas Korte Maatman
NPI 1578944971
$7,981.34
in general payments reported to CMS, 2019-2025
8 companies · $3,552 in 2025
The $3,552 reported for 2025 was more than what 87% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51.97 · 2022: $2,017 · 2023: $136 · 2024: $2,224 · 2025: $3,552.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,800 · Food and Beverage: $1,949 · Travel and Lodging: $948 · Education: $206 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,800.00 |
| Food and Beverage | $1,949.22 |
| Travel and Lodging | $948.26 |
| Education | $206.01 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $3,212.09 | 2025 | Signia, Transorb |
| Intuitive Surgical, INC. | $2,898.69 | 2022-2024 | |
| Histosonics, INC. | $1,305.99 | 2024-2025 | |
| Ethicon US, LLC | $208.40 | 2023-2024 | Surgicel Nu-Knit, Echelon; Endopath, Evarrest |
| Urogen Pharma, INC. | $125.53 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $97.05 | 2023-2025 | Orgovyx |
| Coloplast Corp | $81.62 | 2024 | |
| Davol INC. | $51.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Maatman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.